Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Rouviere et al v. Depuy Orthopaedics, Inc. et al
Case Number:
1:18-cv-04814
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Judge:
Firms
Companies
Sectors & Industries:
-
December 09, 2021
No Reconsideration Of Dismissal In DePuy Hip Implant Suit
A New York federal judge has refused to reconsider his decision to throw out claims against DePuy Orthopaedics Inc. in a patient's suit alleging that components it manufactured for a hip implant were defective, saying the patient's arguments are either rehashes of arguments the court already rejected, or cannot be brought up in a reconsideration.
-
September 17, 2021
DePuy Escapes Implant Suit After Expert Is Limited
A New York federal judge on Friday freed DePuy Orthopaedics Inc. from a suit alleging components it manufactured were defective and caused a hip implant to injure a patient, after finding that an expert's testimony was correctly limited to exclude discussion of DePuy's products.
-
July 13, 2020
Remote Depositions 'New Normal,' Judge Says, Denying Delay
A New York magistrate judge has told a couple suing over a defective hip implant that they can't force a medical company's officers to meet in person for deposition, saying it presents too much risk in the age of COVID-19, when remote depositions are the "new normal."